CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Brief Summary:The FREEDOM study aims to develop a scalable intervention to improve type 2 diabetes mellitus control in low-income Black adul...
Birmingham, Alabama, United States
COORDINATE-Diabetes is a cluster-randomized clinical trial to test the effectiveness of an innovative, clinic-level educational intervention...
Birmingham, Alabama, United States and 43 other locations
This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...
Phase 4
Birmingham, Alabama, United States and 89 other locations
preserving beta-cell function and delaying the progression of type 1 diabetes (T1D) in adolescent and adult patients. The safety of ladarixi...
Phase 3
Birmingham, Alabama, United States and 56 other locations
The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...
Phase 3
Birmingham, Alabama, United States and 652 other locations
double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...
Phase 2
Birmingham, Alabama, United States and 92 other locations
This study will look at how much weight participants will lose and how much blood sugar control they achieve from the start to the end of the study....
Phase 3
Birmingham, Alabama, United States and 66 other locations
This study compares 2 medicines for type 2 diabetes: semaglutide (new medicine) and a dummy medicine (placebo). Semaglutide will be tested t...
Phase 3
Birmingham, Alabama, United States and 90 other locations
weight in adult participants with obesity or overweight and type 2 diabetes. The study will last about 77 weeks and may include up to 22 vis...
Phase 3
Pelham, Alabama, United States and 137 other locations
This study will evaluate the safety and efficacy of ertugliflozin (MK-8835) in pediatric participants with T2DM on metformin with/without insulin. Th...
Phase 3
Birmingham, Alabama, United States and 103 other locations
Clinical trials
Research sites
Resources
Legal